PTC Therapeutics, Inc. PTCT closed lower on Thursday following the company’s decision to withdraw its New Drug Application for Translarna after receiving feedback from the U.S. Food and Drug ...

Boston, Massachusetts-based PTC Inc. (PTC) provides software solutions and services globally that aid manufacturing companies in designing, operating, and managing products. With a market cap. of $18.

In a statement, PTC's chief executive, Matthew Klein, said the company had decided to pull the filing for Translarna (ataluren) as a treatment for nonsense mutation DMD after the FDA said it was ...

Why PTC Stock Is Back in Focus After Earnings and New Client Win PTC (PTC) is back on many investors radar after a combination of better than expected quarterly results, higher full year guidance, and ...

Investing.com -- PTC Inc (NASDAQ:PTC) stock fell 3.8% on Thursday after Google announced a major upgrade to its Gemini 3 Deep Think AI system, potentially challenging PTC’s position in the engineering ...

Product design software company PTC (NASDAQ:PTC) will be reporting earnings this Wednesday after the bell. Here’s what ...

Product design software company PTC (NASDAQ:PTC) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with ...

PTC Inc. (PTC) delivered earnings and revenue surprises of +20.47% and +7.43%, respectively, for the quarter ended December ...

PTC (NASDAQ: PTC) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 20.37%. Currently, PTC has a market capitalization of $24.39 ...